These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 16870665

  • 1. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III.
    Albuquerque AL, Nery LE, Villaça DS, Machado TY, Oliveira CC, Paes AT, Neder JA.
    Eur Respir J; 2006 Nov; 28(5):939-44. PubMed ID: 16870665
    [Abstract] [Full Text] [Related]

  • 2. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.
    Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Díaz H, Celli BR, Pinto-Plata VM.
    Eur Respir J; 2008 Nov; 32(5):1275-82. PubMed ID: 18550609
    [Abstract] [Full Text] [Related]

  • 3. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.
    Ozgür ES, Nayci SA, Özge C, Taşdelen B.
    Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294
    [Abstract] [Full Text] [Related]

  • 4. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O, Gunen H.
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [Abstract] [Full Text] [Related]

  • 5. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ, Botnick WC, Shin JW.
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [Abstract] [Full Text] [Related]

  • 6. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.
    Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR.
    Am J Respir Crit Care Med; 2005 Mar 15; 171(6):591-7. PubMed ID: 15591470
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE.
    Am J Respir Crit Care Med; 2008 Mar 15; 177(6):622-9. PubMed ID: 18006885
    [Abstract] [Full Text] [Related]

  • 8. Inspiratory fraction correlates with exercise capacity in patients with stable moderate to severe COPD.
    Zhang Y, Sun XG, Yang WL, Tan XY, Liu JM.
    Respir Care; 2013 Nov 15; 58(11):1923-30. PubMed ID: 23592787
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
    Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE.
    Am J Respir Crit Care Med; 2009 Nov 15; 180(10):964-71. PubMed ID: 19897773
    [Abstract] [Full Text] [Related]

  • 10. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB.
    Am J Med; 2006 Oct 15; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [Abstract] [Full Text] [Related]

  • 11. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
    Casaburi R, Maltais F, Porszasz J, Albers F, Deng Q, Iqbal A, Paden HA, O'Donnell DE, 205.440 Investigators.
    Ann Am Thorac Soc; 2014 Nov 15; 11(9):1351-61. PubMed ID: 25289942
    [Abstract] [Full Text] [Related]

  • 12. Inspiratory capacity, exercise limitation, markers of severity, and prognostic factors in chronic obstructive pulmonary disease.
    Freitas CG, Pereira CA, Viegas CA.
    J Bras Pneumol; 2007 Nov 15; 33(4):389-96. PubMed ID: 17982530
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control group.
    Felipe C, Bartolome C, Miguel D, Victor PP.
    Chest; 2015 Oct 15; 148(4):986-994. PubMed ID: 25996450
    [Abstract] [Full Text] [Related]

  • 14. Exercise duration rather than peak oxygen uptake better correlates with Fev1 and inspiratory capacity in chronic obstructive pulmonary disease.
    Metin G, Oztürk L, Duman ES, Demir T.
    Arch Med Res; 2007 Nov 15; 38(8):876-81. PubMed ID: 17923270
    [Abstract] [Full Text] [Related]

  • 15. Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1.
    Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF.
    Respir Med; 2013 Jun 15; 107(6):834-40. PubMed ID: 23514950
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
    Ulubay G, Görek A, Savaş S, Oner Eyüboğlu F.
    Tuberk Toraks; 2005 Jun 15; 53(4):340-6. PubMed ID: 16456732
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar 15; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 18. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
    Berton DC, Reis M, Siqueira AC, Barroco AC, Takara LS, Bravo DM, Andreoni S, Neder JA.
    Respir Med; 2010 Sep 15; 104(9):1288-96. PubMed ID: 20580216
    [Abstract] [Full Text] [Related]

  • 19. Breath-by-breath quantification of progressive airflow limitation during exercise in COPD: a new method.
    Ma S, Hecht A, Varga J, Rambod M, Morford S, Goto S, Casaburi R, Porszasz J.
    Respir Med; 2010 Mar 15; 104(3):389-96. PubMed ID: 19931441
    [Abstract] [Full Text] [Related]

  • 20. Lung hyperinflation and functional exercise capacity in patients with COPD - a three-year longitudinal study.
    Aalstad LT, Hardie JA, Espehaug B, Thorsen E, Bakke PS, Eagan TML, Frisk B.
    BMC Pulm Med; 2018 Dec 06; 18(1):187. PubMed ID: 30522466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.